Woodford Investment Management

New guard make their mark

Jeremy Beckwith, director of manager research at Morningstar UK, analyses the key lessons that can be learned from the launch of Neil Woodford's new vehicle last month

The Battle Against Cancer investment trust (BACIT) has backed Woodford's Patient Capital trust at launch.

A chink in the armour?

Neil Woodford's record-breaking Patient Capital investment trust moved to a premium shortly after launching on the London Stock Exchange.

Woodford IM's Patient Capital trust has raised a record £800m during its offer period, and the company will be intent on avoiding the fate suffered by many of its chart-topping predecessors.

Neil Woodford's Patient Capital trust has raised £800m during its offer period, a record for a London-listed investment trust.

Woodford Investment Management, Ruffer, Sarasin and Invesco are among the groups backing a new share placing by Oakley Capital's private equity trust.

Neil Woodford has introduced a currency hedge on his Woodford Equity Income fund for the first time in the belief the European Central Bank's QE programme may prompt further euro weakness.

As Woodford Investment Management gears up for the launch of its Patient Capital investment trust, Investment Week visited the company's Oxford offices to quiz senior personnel about their plans for the future.